- Home
- FTNT vs GSK Comparison
FTNT vs GSK Comparison
Compare FTNT & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTNT
- GSK
- Stock Information
- Founded
- FTNT 2000
- GSK 1715
- Country
- FTNT United States
- GSK United Kingdom
- Employees
- FTNT N/A
- GSK N/A
- Industry
- FTNT Computer peripheral equipment
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- FTNT Technology
- GSK Health Care
- Exchange
- FTNT Nasdaq
- GSK Nasdaq
- Market Cap
- FTNT 70.9B
- GSK 74.6B
- IPO Year
- FTNT 2009
- GSK N/A
- Fundamental
- Price
- FTNT $98.28
- GSK $39.51
- Analyst Decision
- FTNT Buy
- GSK Hold
- Analyst Count
- FTNT 31
- GSK 4
- Target Price
- FTNT $105.04
- GSK $47.00
- AVG Volume (30 Days)
- FTNT 4.9M
- GSK 5.5M
- Earning Date
- FTNT 05-01-2025
- GSK 04-30-2025
- Dividend Yield
- FTNT N/A
- GSK 3.92%
- EPS Growth
- FTNT 54.79
- GSK N/A
- EPS
- FTNT 2.26
- GSK 0.78
- Revenue
- FTNT $5,955,800,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- FTNT $15.99
- GSK $7.60
- Revenue Next Year
- FTNT $13.04
- GSK $5.24
- P/E Ratio
- FTNT $43.48
- GSK $25.42
- Revenue Growth
- FTNT 12.27
- GSK 3.46
- 52 Week Low
- FTNT $54.57
- GSK $31.72
- 52 Week High
- FTNT $114.82
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- FTNT 36.48
- GSK 65.55
- Support Level
- FTNT $105.90
- GSK $36.99
- Resistance Level
- FTNT $110.67
- GSK $40.81
- Average True Range (ATR)
- FTNT 3.78
- GSK 0.66
- MACD
- FTNT -1.81
- GSK 0.19
- Stochastic Oscillator
- FTNT 14.58
- GSK 72.69
About FTNT Fortinet Inc.
Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 700,000 customers across the world.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.